18 May 2013
Keywords: zocor, world, top-selling, drug, merck, co, coronary
Article | 13 January 1997
Merck & Co's coronary disease treatment Zocor (simvastatin) will be theworld's top-selling drug in 2005, according to a new study from
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
13 January 1997
17 May 2013
© 2013 thepharmaletter.com